• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合并哮喘的多发性硬化症患者的病程及临床结局:一项调查研究

Multiple sclerosis course and clinical outcomes in patients with comorbid asthma: a survey study.

作者信息

Manouchehrinia Ali, Edwards Laura J, Roshanisefat Homayoun, Tench Christopher R, Constantinescu Cris S

机构信息

Division of Clinical Neuroscience, Clinical Neurology Research Group, University of Nottingham, Queen's Medical Centre, Nottingham, UK Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.

Division of Clinical Neuroscience, Clinical Neurology Research Group, University of Nottingham, Queen's Medical Centre, Nottingham, UK.

出版信息

BMJ Open. 2015 May 20;5(5):e007806. doi: 10.1136/bmjopen-2015-007806.

DOI:10.1136/bmjopen-2015-007806
PMID:25995241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4442191/
Abstract

OBJECTIVE

To determine if comorbid asthma is associated with accumulation of multiple sclerosis (MS)-related impairment and disability.

METHOD

We sent a comprehensive questionnaire to a cohort of patients with MS and examined the association between comorbid asthma and reaching Expanded Disability Status Scale (EDSS) scores 4.0 and 6.0. Multiple Sclerosis Impact Scale (MSIS-29) scores were compared between patients with MS with and without comorbid asthma.

RESULTS

680 patients participated in our study of whom 88 (12.9%) had comorbid asthma. There was no difference in the prevalence of asthma between our MS cohort and the England general population (OR: 0.89, 95% CI 0.68 to 1.17). We did not observe a significant association between having asthma and the risk of reaching EDSS scores 4.0 and 6.0 (HR: 1.29, 95% CI 0.93 to 1.77, and HR: 1.33, 95% CI 0.93 to 1.89, respectively) after controlling for confounders. Patients with MS with asthma reported higher level of psychological impairments (coefficient: 2.29, 95% CI 0.1 to 4.49).

CONCLUSIONS

Asthma is a prevalent condition among patients with MS and it may contribute to the psychological impairment in MS. Although we did not observe significant association between comorbid asthma and physical disability in MS, it seems that the two conditions influence one another.

摘要

目的

确定合并哮喘是否与多发性硬化症(MS)相关损伤和残疾的累积有关。

方法

我们向一组MS患者发送了一份综合问卷,并研究了合并哮喘与扩展残疾状态量表(EDSS)评分达到4.0和6.0之间的关联。比较了合并哮喘和未合并哮喘的MS患者的多发性硬化症影响量表(MSIS - 29)评分。

结果

680名患者参与了我们的研究,其中88名(12.9%)合并哮喘。我们的MS队列与英格兰普通人群的哮喘患病率无差异(OR:0.89,95%CI 0.68至1.17)。在控制混杂因素后,我们未观察到患哮喘与EDSS评分达到4.0和6.0的风险之间存在显著关联(HR分别为:1.29,95%CI 0.93至1.77;以及HR:1.33,95%CI 0.93至1.89)。合并哮喘患MS的患者报告心理损伤水平较高(系数:2.29,95%CI 0.1至4.49)。

结论

哮喘在MS患者中很常见,可能导致MS患者的心理损伤。虽然我们未观察到合并哮喘与MS患者身体残疾之间存在显著关联,但这两种疾病似乎相互影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b78d/4442191/16c8be5af6d1/bmjopen2015007806f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b78d/4442191/f83c3043de92/bmjopen2015007806f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b78d/4442191/16c8be5af6d1/bmjopen2015007806f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b78d/4442191/f83c3043de92/bmjopen2015007806f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b78d/4442191/16c8be5af6d1/bmjopen2015007806f02.jpg

相似文献

1
Multiple sclerosis course and clinical outcomes in patients with comorbid asthma: a survey study.合并哮喘的多发性硬化症患者的病程及临床结局:一项调查研究
BMJ Open. 2015 May 20;5(5):e007806. doi: 10.1136/bmjopen-2015-007806.
2
Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.多发性硬化症影响量表(MSIS - 29):与既定的损伤和残疾测量方法的关系
Mult Scler. 2004 Oct;10(5):569-74. doi: 10.1191/1352458504ms1078oa.
3
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.大麻素用于进行性炎症性脑病(CUPID)试验:一项随机双盲安慰剂对照平行组多中心试验及大麻素延缓多发性硬化症进展的经济学评估。
Health Technol Assess. 2015 Feb;19(12):vii-viii, xxv-xxxi, 1-187. doi: 10.3310/hta19120.
4
Concomitant autoimmunity and risk of multiple sclerosis disability worsening.伴随自身免疫与多发性硬化症残疾恶化风险。
Mult Scler Relat Disord. 2024 Jul;87:105637. doi: 10.1016/j.msard.2024.105637. Epub 2024 May 1.
5
Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.多发性硬化症共病的频率及其与临床残疾和复发的关系。
Neuroepidemiology. 2016;46(2):106-13. doi: 10.1159/000442203. Epub 2016 Jan 20.
6
Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context.普遍医疗保健背景下的发病前社会人口统计学状况与多发性硬化症结局。
JAMA Netw Open. 2023 Sep 5;6(9):e2334675. doi: 10.1001/jamanetworkopen.2023.34675.
7
Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study.经检验与验证:基于人群研究中多发性硬化症影响量表(MSIS - 29)的心理测量特性。
Mult Scler. 2009 Jan;15(1):75-80. doi: 10.1177/1352458508096872. Epub 2008 Oct 1.
8
Disability measurement in Multiple Sclerosis patients 55 years and older: What is the Expanded Disability Status Scale really telling clinicians?55岁及以上多发性硬化症患者的残疾评估:扩展残疾状态量表究竟向临床医生传达了什么信息?
Mult Scler Relat Disord. 2021 Apr;49:102724. doi: 10.1016/j.msard.2020.102724. Epub 2020 Dec 28.
9
Hospitalization is associated with subsequent disability in multiple sclerosis.住院治疗与多发性硬化症患者随后出现的残疾有关。
Mult Scler Relat Disord. 2017 May;14:23-28. doi: 10.1016/j.msard.2017.03.009. Epub 2017 Mar 24.
10
The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical).患者最有发言权:多发性硬化症影响量表(MSIS - 29身体部分)身体方面的显著变化。
J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):841-4. doi: 10.1136/jnnp.2006.105759. Epub 2007 Mar 1.

引用本文的文献

1
Comorbidity and Disease Activity in Multiple Sclerosis.多发性硬化症中的共病与疾病活动度
JAMA Neurol. 2024 Sep 18;81(11):1170-7. doi: 10.1001/jamaneurol.2024.2920.
2
House dust mite-induced asthma exacerbates Alzheimer's disease changes in the brain of the App mouse model of disease.屋尘螨诱导的哮喘加重了 App 疾病模型小鼠大脑中的阿尔茨海默病变化。
Brain Behav Immun. 2024 Oct;121:365-383. doi: 10.1016/j.bbi.2024.07.038. Epub 2024 Jul 29.
3
Investigating the Effect of Cigarette Smoking on Serum Uric Acid Levels in Multiple Sclerosis Patients: A Cross Sectional Study.

本文引用的文献

1
The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial.吸入式干扰素-β对病毒感染所致哮喘症状恶化的影响。一项随机试验。
Am J Respir Crit Care Med. 2014 Jul 15;190(2):145-54. doi: 10.1164/rccm.201312-2235OC.
2
Tobacco smoking and excess mortality in multiple sclerosis: a cohort study.吸烟与多发性硬化症患者的超额死亡率:一项队列研究。
J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1091-5. doi: 10.1136/jnnp-2013-307187. Epub 2014 Feb 25.
3
Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study.
调查吸烟对多发性硬化症患者血清尿酸水平的影响:一项横断面研究。
Brain Sci. 2023 May 15;13(5):800. doi: 10.3390/brainsci13050800.
4
PAF-R on activated T cells: Role in the IL-23/Th17 pathway and relevance to multiple sclerosis.活化 T 细胞上的 PAF-R:在 IL-23/Th17 通路中的作用及其与多发性硬化症的相关性。
Immunobiology. 2021 Jan;226(1):152023. doi: 10.1016/j.imbio.2020.152023. Epub 2020 Nov 13.
5
Comorbidity in Multiple Sclerosis.多发性硬化症中的合并症
Front Neurol. 2020 Aug 21;11:851. doi: 10.3389/fneur.2020.00851. eCollection 2020.
6
A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications.多发性硬化症共病的全球视角:一项系统综述,重点关注区域差异、方法学和临床意义。
J Neurol. 2021 Nov;268(11):4066-4077. doi: 10.1007/s00415-020-10107-y. Epub 2020 Jul 27.
7
Comorbidities in multiple sclerosis-a plea for interdisciplinary collaboration to improve the quality of life of MS patients.多发性硬化症的合并症——呼吁跨学科合作以改善多发性硬化症患者的生活质量。
Degener Neurol Neuromuscul Dis. 2019 Jun 13;9:39-53. doi: 10.2147/DNND.S204555. eCollection 2019.
8
Challenges in the management of severe allergic asthma in the elderly.老年重度过敏性哮喘管理中的挑战。
J Asthma Allergy. 2016 Mar 17;9:55-63. doi: 10.2147/JAA.S85420. eCollection 2016.
吸烟与多发性硬化症残疾进展的关系:英国队列研究。
Brain. 2013 Jul;136(Pt 7):2298-304. doi: 10.1093/brain/awt139. Epub 2013 Jun 11.
4
Modelling genetic susceptibility to multiple sclerosis with family data.利用家族数据建立多发性硬化症的遗传易感性模型。
Neuroepidemiology. 2013;40(1):1-12. doi: 10.1159/000341902. Epub 2012 Oct 11.
5
Shared genetic factors may not explain the raised risk of comorbid inflammatory diseases in multiple sclerosis.共享的遗传因素可能无法解释多发性硬化症中并发炎症性疾病风险增加的原因。
Mult Scler. 2012 Oct;18(10):1430-6. doi: 10.1177/1352458512438240. Epub 2012 Mar 14.
6
Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma.过敏性哮喘患者中存在 Th1/Th2 和 Th17/Treg 失衡。
Chin Med J (Engl). 2011 Jul 5;124(13):1951-6.
7
Central inflammation versus peripheral regulation in multiple sclerosis.多发性硬化症中的中枢炎症与外周调节。
J Neurol. 2011 Aug;258(8):1518-27. doi: 10.1007/s00415-011-5973-5. Epub 2011 Mar 9.
8
Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus.外源性 IFN-β 在暴露于鼻病毒的哮喘患者的原代支气管上皮细胞中具有抗病毒和抗炎特性。
J Allergy Clin Immunol. 2011 May;127(5):1148-54.e9. doi: 10.1016/j.jaci.2011.01.023. Epub 2011 Feb 16.
9
Use of oestrogen only hormone replacement therapy associated with increased risk of asthma onset in postmenopausal women.仅使用雌激素的激素替代疗法与绝经后女性哮喘发病风险增加有关。
Evid Based Med. 2010 Dec;15(6):190-1. doi: 10.1136/ebm1135. Epub 2010 Sep 22.
10
Emerging effects of comorbidities on multiple sclerosis.共病对多发性硬化症的新影响。
Lancet Neurol. 2010 Aug;9(8):820-8. doi: 10.1016/S1474-4422(10)70135-6.